Search

Your search keyword '"Nij Bijvanck, B. W.A."' showing total 6 results
Start Over Author "Nij Bijvanck, B. W.A."
6 results on '"Nij Bijvanck, B. W.A."'

1. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor

Author

van Baaren, G. J., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., Vandenbussche, F. P.H.A., Woiski, M., Bolte, A. C., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., Mol, B. W.J., van Baaren, G. J., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., Vandenbussche, F. P.H.A., Woiski, M., Bolte, A. C., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., and Mol, B. W.J.

Published
2018

2. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor

Author

van Baaren, G. J., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., Vandenbussche, F. P.H.A., Woiski, M., Bolte, A. C., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., Mol, B. W.J., van Baaren, G. J., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., Vandenbussche, F. P.H.A., Woiski, M., Bolte, A. C., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., and Mol, B. W.J.

Published
2018

3. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor

Author

van Baaren, G. J., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., Vandenbussche, F. P.H.A., Woiski, M., Bolte, A. C., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., Mol, B. W.J., van Baaren, G. J., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., Vandenbussche, F. P.H.A., Woiski, M., Bolte, A. C., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., and Mol, B. W.J.

Published
2018

4. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor

Author

UMC Utrecht, CDL Klinisch Chemici in opleiding, MS Verloskunde, Other research (not in main researchprogram), Geboortecentrum voorzitterschap, van Baaren, G. J., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., Vandenbussche, F. P.H.A., Woiski, M., Bolte, A. C., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., Mol, B. W.J., UMC Utrecht, CDL Klinisch Chemici in opleiding, MS Verloskunde, Other research (not in main researchprogram), Geboortecentrum voorzitterschap, van Baaren, G. J., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., Vandenbussche, F. P.H.A., Woiski, M., Bolte, A. C., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., and Mol, B. W.J.

Published
2018

5. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women

Author

Bruijn, M. M.C., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Oei, G., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bolte, A. C., Vandenbussche, F. P.H.A., Woiski, M. D., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., Kok, M., Mol, B. W.J., van Baaren, G. J., Bruijn, M. M.C., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Oei, G., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bolte, A. C., Vandenbussche, F. P.H.A., Woiski, M. D., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., Kok, M., Mol, B. W.J., and van Baaren, G. J.

Abstract

Objective: To evaluate whether in symptomatic women, the combination of quantitative fetal fibronectin (fFN) testing and cervical length (CL) improves the prediction of preterm delivery (PTD) within 7 days compared with qualitative fFN and CL. Design: Post hoc analysis of frozen fFN samples of a nationwide cohort study. Setting: Ten perinatal centres in the Netherlands. Population: Symptomatic women between 24 and 34 weeks of gestation. Methods: The risk of PTD <7 days was estimated in predefined CL and fFN strata. We used logistic regression to develop a model including quantitative fFN and CL, and one including qualitative fFN (threshold 50 ng/ml) and CL. We compared the models’ capacity to identify women at low risk (<5%) for delivery within 7 days using a reclassification table. Main outcome measures: Spontaneous delivery within 7 days after study entry. Results: We studied 350 women, of whom 69 (20%) delivered within 7 days. The risk of PTD in <7 days ranged from 2% in the lowest fFN group (<10 ng/ml) to 71% in the highest group (>500 ng/ml). Multivariable logistic regression showed an increasing risk of PTD in <7 days with rising fFN concentration [10–49 ng/ml: odds ratio (OR) 1.3, 95% confidence interval (95% CI) 0.23–7.0; 50–199 ng/ml: OR 3.2, 95% CI 0.79–13; 200–499 ng/ml: OR 9.0, 95% CI 2.3–35; >500 ng/ml: OR 39, 95% CI 9.4–164] and shortening of the CL (OR 0.86 per mm, 95% CI 0.82–0.90). Use of quantitative fFN instead of qualitative fFN resulted in reclassification of 18 (5%) women from high to low risk, of whom one (6%) woman delivered within 7 days. Conclusion: In symptomatic women, quantitative fFN testing does not improve the prediction of PTD within 7 days compared with qualitative fFN testing in combination with CL measurement in terms of reclassification from high to low (<5%) risk, but it adds value across the risk range. Tweetable abstract: Quantitative fFN testing adds value to qualitative fFN testing with CL measurem

Published
2016

6. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women

Author

Bruijn, M. M.C., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Oei, G., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bolte, A. C., Vandenbussche, F. P.H.A., Woiski, M. D., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., Kok, M., Mol, B. W.J., van Baaren, G. J., Bruijn, M. M.C., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Oei, G., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bolte, A. C., Vandenbussche, F. P.H.A., Woiski, M. D., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., Kok, M., Mol, B. W.J., and van Baaren, G. J.

Abstract

Objective: To evaluate whether in symptomatic women, the combination of quantitative fetal fibronectin (fFN) testing and cervical length (CL) improves the prediction of preterm delivery (PTD) within 7 days compared with qualitative fFN and CL. Design: Post hoc analysis of frozen fFN samples of a nationwide cohort study. Setting: Ten perinatal centres in the Netherlands. Population: Symptomatic women between 24 and 34 weeks of gestation. Methods: The risk of PTD <7 days was estimated in predefined CL and fFN strata. We used logistic regression to develop a model including quantitative fFN and CL, and one including qualitative fFN (threshold 50 ng/ml) and CL. We compared the models’ capacity to identify women at low risk (<5%) for delivery within 7 days using a reclassification table. Main outcome measures: Spontaneous delivery within 7 days after study entry. Results: We studied 350 women, of whom 69 (20%) delivered within 7 days. The risk of PTD in <7 days ranged from 2% in the lowest fFN group (<10 ng/ml) to 71% in the highest group (>500 ng/ml). Multivariable logistic regression showed an increasing risk of PTD in <7 days with rising fFN concentration [10–49 ng/ml: odds ratio (OR) 1.3, 95% confidence interval (95% CI) 0.23–7.0; 50–199 ng/ml: OR 3.2, 95% CI 0.79–13; 200–499 ng/ml: OR 9.0, 95% CI 2.3–35; >500 ng/ml: OR 39, 95% CI 9.4–164] and shortening of the CL (OR 0.86 per mm, 95% CI 0.82–0.90). Use of quantitative fFN instead of qualitative fFN resulted in reclassification of 18 (5%) women from high to low risk, of whom one (6%) woman delivered within 7 days. Conclusion: In symptomatic women, quantitative fFN testing does not improve the prediction of PTD within 7 days compared with qualitative fFN testing in combination with CL measurement in terms of reclassification from high to low (<5%) risk, but it adds value across the risk range. Tweetable abstract: Quantitative fFN testing adds value to qualitative fFN testing with CL measurem

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results